Manufacturer's investigation conclusion: a direct correlation between the heartmate (hm) 3 left ventricular assist system (lvas) and the reported events could not be conclusively determined through this investigation.The heartmate 3 device serial numbers and other specific case/patient information are not available and were not requested.No product was evaluated under this complaint.The heartmate 3 (hm3) left ventricular assist system (lvas) instructions for use (ifu), rev.C, is currently available.Section 1 of this ifu lists right heart failure, stroke, bleeding, infection, and cardiac arrhythmia as adverse events that may be associated with the use of the heartmate 3 left ventricular assist system.Section 6, ¿patient care and management¿ (under ¿right heart failure), states that patients may develop right ventricular failure during or shortly after implant and outlines the associated treatment options.Section 6 (under ¿caution!¿) further explains that right ventricular dysfunction, especially when combined with elevated pulmonary vascular resistance, may limit the effectiveness of the left ventricular assist system due to reduced filling of the pump.Section 6 (under "anticoagulation") also outlines the recommended anticoagulation regimen (including inr range) for patients using the heartmate 3 lvas, as well as the suggested anticoagulation modifications in the event that there is a risk of bleeding.Additionally, section 6 lists arrhythmia as a potential late postimplant complication that may be associated with the use of heartmate 3 lvas.Care instructions in regard to preventing infection are provided in various sections of the ifu, including caring for the driveline exit site and controlling infection.The heartmate 3 lvas patient handbook, rev.D, also contains information about caring for the driveline and preventing infection.The serial numbers or other identifying information of the products were not reported and were not able to be determined during the investigation.No further information was provided.The manufacturer is closing the file on this event.
|
Related mfr # 2916596-2024-01786.It was reported through the research article ¿the impact of small left ventricular dimension on outcomes after heartmate 3 lvad implantation¿ that the heartmate 3 (hm3) device may be associated with right heart failure, stroke, bleeding, infection, arrhythmia.This retrospective study compared 2-year survival and adverse events of the 1921 patients implanted with hm3 devices within the momentum 3 trial portfolio.The patients were compared based on the presence or absence of a left ventricular end diastolic diameter (lvedd) of < 55 mm (millimeters).Of the 1921 patients, 108 had lvedd < 55mm, and 1813 had lvedd >= 55mm.Instances of right heart failure were greater in the smaller lvedd group (41.7 vs.36.9%; p= 0.03).The need for right ventricular mechanical support, stroke, bleeding, infections, and arrhythmias were reported to have similar rates between the two groups.
|